Service Corporation Inter... (SCI)

NYSE: SCI · Real-Time Price · USD

79.68

-0.42 (-0.52%)

At close: Apr 30, 2025, 3:59 PM

75.55

-5.18%

Pre-market: May 01, 2025, 07:21 AM EDT

-0.52% (1D)

Bid	75.55
Market Cap	11.48B
Revenue (ttm)	4.19B
Net Income (ttm)	518.65M
EPS (ttm)	3.53
PE Ratio (ttm)	22.57
Forward PE	18.79
Analyst	Strong Buy

Ask	84.3
Volume	1,247,334
Avg. Volume (20D)	1,314,554
Open	79.84
Previous Close	80.10
Day's Range	78.48 - 80.03
52-Week Range	67.19 - 89.37
Beta	0.82

About SCI

Service Corporation International provides deathcare products and services in the United States and Canada. The company operates through Funeral and Cemetery segments. Its funeral service and cemetery operations comprise funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and other businesses. The company also provides professional services related to funerals and cremations, including the use of fun...

[Read more]

Industry Personal Products & Services

Sector Consumer Cyclical

IPO Date Mar 17, 1980

Employees 17,685

Stock Exchange NYSE

Ticker Symbol SCI

Website https://www.sci-corp.com

Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for SCI stock is "Strong Buy." The 12-month stock price forecast is $88.5, which is an increase of 11.07% from the latest price.

Stock Forecasts

Earnings Surprise

New

Service International has released their quartely earnings on Apr 30, 2025:

Revenue of $1.07B exceeds estimates by $14M, with 2.78% YoY growth.

EPS of 0.96 exceeds estimates by 0.05, with 7.87% YoY growth.

Why Price Moved

Just now New

SCI stock has given up its prior gain. Service Cor... Unlock content with Pro Subscription

Just now New

Service Corp International shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY25 adjusted EPS guidance with its midpoint above estimates.

News

15 hours ago · zacks.com

Service Corp. (SCI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Service Corp. (SCI) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street est...

16 hours ago · zacks.com

Service Corp. (SCI) Q1 Earnings and Revenues Surpass Estimates

Service Corp. (SCI) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.89 per share a year ago.

5 days ago · zacks.com

Service Corp Set to Report Q1 Earnings: Here's What to Expect

SCI's Q1 performance is likely to have gained from a resilient business model and favorable demographic trends.

1 week ago · businesswire.com

CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to file for Regulatory Approval of Multikine in Saudi Arabia—Pursuing local partnerships to serve Middle East and North Africa Market.

3 weeks ago · businesswire.com

New Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI's Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--New study in the scientific journal “Cancer Cell” supports CEL-SCI's strategy to seek early approval for Multikine.

4 weeks ago · seekingalpha.com

Service Corporation: Benefiting From Aging Population; Strong Buy

Service Corporation International is well-positioned post-pandemic, benefiting from an aging population and potential corporate tax cuts, with a 'Strong Buy' rating and a fair value of $98 per share. ...

1 month ago · businesswire.com

CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI reports new data. Treatment with Multikine resulted in up to 95% improvement in Quality of Life for Head and Neck Cancer Patients.

1 month ago · businesswire.com

CEL-SCI Announces Closing of $2.5 Million Offering

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces closing of $2.5 million offering .

1 month ago · businesswire.com

CEL-SCI Announces Pricing of $2.5 Million Offering

VIENNA, Va.--(BUSINESS WIRE)---- $CVM--CEL-SCI announces pricing of $2.5 million offering.

1 month ago · businesswire.com

Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI's Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of Head and Neck Patients.

Load More News